India Glycols Limited · NSE:INDIAGLYCO
India Glycols — Q1 FY2025 Earnings Presentation
37 slides from India Glycols's earnings presentation, Jul 31, 2024
Slide 1: Stock exchange cover letter for investor presentation
31st July, 2024 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (East), Mumbai- 400 051 Scrip Code: 5
Slide 2: Investor Presentation Q1FY25
Investor Presentation Q1FY25 July 2024
Slide 3: Safe Harbor Statement
Safe Harbor Statement This presentation and the following discussion may contain “forward looking statements” by India Glycols Limited (“IGL” or the company) that are not historical in nature. These forward-looking statements, which may include statements relating to future results of operations, fi
Slide 4: Table of Contents
Table of Contents Q1FY25 Financial Highlights Q1FY25 Segmental Highlights Business Overview Annual Financial Highlights Annexures
Slide 5: Q1FY25 Financial Highlights
Q1FY25 Financial Highlights
Slide 6: Q1FY25 Performance Overview
Q1FY25 Performance Overview Figures in ₹ Cr. Gross Revenue Net Revenue EBITDA & EBITDA Margin PAT & PAT Margin +21% 15.2% 13.2% 7.4% 6.2% 2,283 250 1,894 +41% 200 +21% 969 150 128 689 + 18% 106 60 100 51 50 - Q1FY24 Q1FY25 Q1FY24 Q1FY25 Q1FY24 Q1FY25 Q1FY24 Q1FY25 ⦁ Reported an excellent Revenue and
Slide 7: Highlights – Q1FY25
Highlights – Q1FY25 Business Performance Figures in ₹ Cr. Q1FY25 over Q1FY24 Net Revenue surged by 40.6% in Q1FY25 – BSPC up by 16.8% YoY to ₹ 393 Cr – Bio-Fuel increased from ₹ 65 Cr To ₹ 239 Cr – PS up by 19.1% YoY to ₹ 280 Cr – EB marginally up by 8.1% YoY to ₹ 57 Cr EBITDA increased by 21.3%
Slide 8: Highlights – Q1FY25 Other Highlights
Highlights – Q1FY25 Figures in ₹ Cr. Other Highlights NSU – commissioning nearly complete, good commercialization to high-capacity utilization, planning incremental expansions. Strong foundation for growth in several areas which will help build the value-added business. JV Strong Recovery in mar
Slide 9: Financial Summary - Consolidated
Financial Summary - Consolidated Figures in ₹ Cr. Y-o-Y Q-o-Q Y-o-Y Particulars Q1FY25 Q1FY24 Q4FY24 FY24 FY23 (%) (%) (%) Gross Revenue from Operations 2,283 1,894 20.5% 2,039 11.9% 7,922 6,642 19.3% Revenue from Operations (Net of excise) 969 689 40.6% 926 4.6% 3,294 2,651 24.3% Other Income 3 6 5
Slide 10: Financial Summary - Standalone
Financial Summary - Standalone Figures in ₹ Cr. Y-o-Y Q-o-Q Y-o-Y Particulars Q1FY25 Q1FY24 Q4FY24 FY24 FY23 (%) (%) (%) Gross Revenue from Operations 2,282 1,892 20.6% 2,037 12.1% 7,919 6,641 19.2% Revenue from Operations (net of excise) 968 688 40.8% 924 4.9% 3,291 2,650 24.2% Other Income 3 6 5 2
Slide 11: Q1FY25 Segmental Highlights
Q1FY25 Segmental Highlights
Slide 12: Segmental Highlights – Q1FY25
Segmental Highlights – Q1FY25 Net Revenue and EBIT Margin (%) Figures in ₹ Cr. Bio-Based Specialties and Potable Spirits (PS) Performance Chemicals (BSPC) 11.4% 9.9% 18.3% 17.5% 500 500 450 450 400 400 350 350 300 300 250 250 393 200 336 200 235 280 150 150 100 100 50 50 - - Q1FY24 Q1FY25 Q1FY24 Q1F
Slide 13: Segmental Revenue and EBIT Mix - Consolidated
Segmental Revenue and EBIT Mix - Consolidated Revenue Mix EBIT Mix 8% 5% 6% 14% 40% 29% 49% 35% 39% 43% 34% 44% 9% 17% 25% 3% Q1FY25 Q1FY24 Q1FY25 Q1FY24 BSPC Bio-Fuel PS EB Consolidated Financials Note – The company has started reporting Bio-Fuel as a separate segment from Q1FY25, which was earlier
Slide 14: Segment Performance – BSPC
Segment Performance – BSPC Figures in ₹ Cr. Particulars Q1FY25 Q1FY24 % YoY Q4FY24 % QoQ Bio-based Specialities and Performance Chemicals (BSPC) Net Revenue 393 336 16.8% 439 (10.4%) EBIT 39 38 1.2% 34 14.2% % margin 9.9% 11.4% (152 bps) 7.7% 213 bps Q1 Revenue at ₹ 393 Cr., up by 16.8%; EBIT at ₹
Slide 15: Segment Performance – Bio-Fuel
Segment Performance – Bio-Fuel Figures in ₹ Cr. Particulars Q1FY25 Q1FY24 % YoY Q4FY24 % QoQ Bio-based Specialities and Performance Chemicals (BSPC) Net Revenue 239 65 267.6% 195 29.5% EBIT 19 3 500.6% 13 40.9% % margin 7.8% 4.8% 303 bps 7.2% 63 bps Q1 Revenue at ₹ 239 Cr., up by 267.6%; EBIT at ₹
Slide 16: Segment Performance - PS
Segment Performance - PS Figures in ₹ Cr. Particulars Q1FY25 Q1FY24 % YoY Q4FY24 % QoQ Portable Spirits (PS) Net Revenue 280 235 19.1% 247 13.1% EBIT 49 43 14.2% 40 22.7% % margin 17.5% 18.3% (75 bps) 16.2% 138 bps Q1FY24 Revenue at ₹ 280 Cr, up by 19.1%; EBIT at ₹ 49 Cr., up 14.2%, EBIT margin at
Slide 17: Segment Performance - EB
Segment Performance - EB Figures in ₹ Cr. Particulars Q1FY25 Q1FY24 % YoY Q4FY24 % QoQ Ennature Biopharma (EB) Net Revenue 57 53 8.1% 56 2.0% EBIT 6 13 (49.6%) 7 (6.9%) % margin 11.4% 24.3% (1,298 bps) 12.4% (109 bps) Q1FY25 Revenue at ₹ 57 Cr; up by 8.1% YoY; EBIT margin at 11.4%, stood at ₹ 6 Cr
Slide 18: Business Overview
Business Overview
Slide 19: Company at a Glance
Company at a Glance Business Overview India Glycols Limited (IGL), founded in 1983, is one of the leading manufacturer of Bio-based Specialties & Performance ₹ 3,294 Cr ₹ 428 Cr Chemicals (BSPC), Bio-Fuel, Potable Spirits (PS) and Ennature Biopharma (EB). It is the first company in the world to prod
Slide 20: Key Strengths
Key Strengths 3+ decades of presence 3x3 strategy for Cost Effectiveness Diversified business R&D: Creating value with focus on Green model and applications Chemistry & Technical collaborations India’s leading Green Chemical Strong Management Team Company Integrated Mfg. facilities - 3 Financials pe
Slide 21: IGL Journey of more than 3 decades
IGL Journey of more than 3 decades 1983-1993 1994 - 2000 2001-2007 2008-2019 2020-2024 1983: Incorporation as 1994: Commissioning of EO 2001: Starting of glycol 2008: Expansion of MEG 2020: Commissioning of UP Glycols Ltd purification and first ether plant and gaur gum plant and commissioning saniti
Slide 22: Diversified business model and multi-functional application
Diversified business model and multi-functional application Business segments Bio-based Specialities and Potable Spirits (PS) Ennature Biopharma (EB) Performance Chemicals (BSPC) Bio Glycols: Bio Mono Ethylene Glycol, Bio Di Ethylene Glycol, License for operations and sale of Country Liquor in the N
Slide 23: India’s leading Green Chemical Company
India’s leading Green Chemical Company Green is in IGL’s DNA and is the core of our business: Inspired by nature and Green chemistry, we create compounds based on decades of expertise, innovative engineering and sustainable technologies, while ensuring our environment remains untouched. Only manufac
Slide 24: Capabilities
Integrated Manufacturing facilities Kashipur Gorakhpur Dehradun 300-acre state 56-acre state of of art integrated art distillation & 1,60,000 sqft state manufacturing bottling complex of art facility complex Fermentation – Molasses and Grain Based Grain based Ethanol High Purity Extraction E
Slide 25: Leveraging synergies to create value–integrated manufacturing
Leveraging synergies to create value–integrated manufacturing for bio-based products Portable Spirits (PS) Products Bio-Fuels Potable Power Industrial ENA O2, N2, Ar Spirit Brands Alcohol Gas Division Ind Gr. CO2 Food grade from distillery O2 ASU EO-CO2 mix Grain Distillery Bio-Ethanol Bio-Ethylene
Slide 26: 3 x 3 Model – Resilient Business
3 x 3 Model – Resilient Business Mitigating costs with 3 possible sources of 3 possible outputs raw material Imported Bio-based Ethanol Chemicals Domestically Bio-fuels bought Ethanol In-house Potable Ethanol Spirits • Grain-based ethanol plants with capacities of 400 KLPD and 110 KLPD at Kashipur a
Slide 27: R&D: Value through Green Chemistry & Partnerships
R&D: Value through Green Chemistry & Partnerships IGL pioneers’ sustainable trends with innovative, technology-driven solutions that reduce carbon footprints, leveraging digital technologies to reach net zero emissions and lead the way in green innovation. The state-of-the- New range of products in
Slide 28: Growth Drivers
Growth Drivers High prospects of growth of Increasing consumer Companies taking steps to Growing demand for natural IGL is ideally placed to seize industry sectors being awareness and demand for significantly decrease carbon and safer products in the opportunity arising out serviced by IGL – Persona
Slide 29: Annual Financial Highlights
Annual Financial Highlights
Slide 30: 3-year Financial Trajectory - Consolidated
3-year Financial Trajectory - Consolidated Figures in ₹ Cr. Gross Revenue Net Revenue 7,922 3,294 2,868 6,601 6,642 2,651 FY22 FY23 FY24 FY22 FY23 FY24 EBITDA & EBITDA Margin (%) Adj. PAT* & Adj. PAT Margin (%) 9.6% 11.9% 12.9% 4.1% 4.2% 5.2% 428 319 277 173 119 113 FY22 FY23 FY24 FY22 FY23 FY24 * P
Slide 31: 3-year Key Ratios - Consolidated
3-year Key Ratios - Consolidated Return on Capital Employed (%) Debt-to-Equity Ratio (x) 10.5% 0.64 0.59 0.58 7.5% 7.7% FY22 FY23 FY24 FY22 FY23 FY24 Cash Conversion Cycle* (Days) Interest Coverage Ratio (x) 60 59 43 2.82 2.71 2.26 FY22 FY23 FY24 FY22 FY23 FY24 * Cash Conversion Cyle = Debtor Days +
Slide 32: Financial Summary - Consolidated
Financial Summary - Consolidated Figures in ₹ Cr. Particulars (In ₹ Cr) FY22 FY23 FY24 FY22-24 CAGR Gross Revenue from operations 6,601 6,642 7,922 9.5% Revenue from operations (Net of excise) 2,868 2,651 3,294 7.2% Other Income 22 24 26 Total Income 2,890 2,675 3,320 7.2% EBITDA 277 319 428 24.4% E
Slide 33: Financial Summary - Consolidated
Financial Summary - Consolidated Figures in ₹ Cr. Balance Sheet Cash Flow Statement Particulars (₹ Cr.) (as at end of) FY22 FY23 FY24 Particulars (₹ Mn) FY22 FY23 FY24 Fixed Assets 2,303 2,690 3,171 Cash and Cash Equivalents (Opening Balance) 3 7 2 CWIP 243 125 84 Investment 336 318 335 Cash Flow fr
Slide 34: Annexures
Annexures
Slide 35: Shareholder’s Information
Shareholder’s Information Shareholding Pattern Shareholder Information as on 30th June 2024 BSE Ticker 500201 Public & NSE Symbol INDIAGLYCO Others, 31.19% Market Cap (in ₹ Cr.) 2,740.4 % Free- float 39.0% as on 30th June Free Float Market Cap (in ₹ Cr.) 1,068.5 Bodies 2024 Shares Outstanding (Cr.)
Slide 36: Sustainability, ESG
Sustainability, ESG Social Environment Governance Adherence to high safety and operational standards for handling hazardous materials. Employee and worker training for skill development. Implementation of preventive measures to enhance cyber security. Stakeholder engagement approach implemen
Slide 37: India Glycols Limited contact details
India Glycols Limited Ernst & Young LLP CIN: L24111UR1983PLC009097 Rohit Anand Ankur Jain rohit.anand4@in.ey.com Company Secretary & Compliance Officer Riddhant Kapur Riddhant.kapur@in.ey.com Head office 2B, Sector-126, Noida Anubhav Khandelwal Gautam Budh Nagar Anubhav.khandelwal@in.ey.com Uttar Pr